Concepts (314)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 28 | 2025 | 121 | 4.610 |
Why?
|
| Republic of Korea | 83 | 2025 | 133 | 3.600 |
Why?
|
| Risk Factors | 96 | 2025 | 3942 | 2.550 |
Why?
|
| Incidence | 63 | 2025 | 1054 | 2.350 |
Why?
|
| Stroke | 14 | 2023 | 348 | 1.660 |
Why?
|
| Bronchiectasis | 8 | 2025 | 13 | 1.660 |
Why?
|
| Tuberculosis | 9 | 2024 | 76 | 1.660 |
Why?
|
| Cohort Studies | 46 | 2025 | 1729 | 1.600 |
Why?
|
| Drosophila Proteins | 4 | 2024 | 183 | 1.560 |
Why?
|
| Aged | 74 | 2025 | 7982 | 1.450 |
Why?
|
| Middle Aged | 93 | 2025 | 11819 | 1.420 |
Why?
|
| Proportional Hazards Models | 28 | 2025 | 512 | 1.310 |
Why?
|
| Drosophila melanogaster | 4 | 2024 | 189 | 1.290 |
Why?
|
| Hypertension | 10 | 2025 | 823 | 1.270 |
Why?
|
| Female | 103 | 2025 | 24018 | 1.180 |
Why?
|
| Male | 100 | 2025 | 22779 | 1.170 |
Why?
|
| Adult | 79 | 2025 | 13458 | 1.150 |
Why?
|
| Kidney Failure, Chronic | 4 | 2025 | 239 | 1.150 |
Why?
|
| Humans | 134 | 2025 | 42163 | 1.140 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2025 | 53 | 1.060 |
Why?
|
| Mushroom Bodies | 2 | 2020 | 3 | 1.060 |
Why?
|
| Diabetes Mellitus | 5 | 2024 | 532 | 1.030 |
Why?
|
| Nutrition Surveys | 13 | 2020 | 263 | 0.970 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2023 | 188 | 0.960 |
Why?
|
| Databases, Factual | 17 | 2025 | 336 | 0.930 |
Why?
|
| Cardiomyopathy, Hypertrophic | 5 | 2023 | 24 | 0.900 |
Why?
|
| Dopamine | 2 | 2024 | 272 | 0.890 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2025 | 164 | 0.890 |
Why?
|
| Keratosis, Actinic | 2 | 2021 | 4 | 0.880 |
Why?
|
| Ethanol | 2 | 2024 | 221 | 0.870 |
Why?
|
| Receptors, Dopamine | 2 | 2024 | 30 | 0.860 |
Why?
|
| Myocardial Infarction | 8 | 2023 | 242 | 0.840 |
Why?
|
| Dementia, Vascular | 5 | 2023 | 36 | 0.800 |
Why?
|
| Psoriasis | 5 | 2021 | 19 | 0.800 |
Why?
|
| Suicide | 4 | 2025 | 139 | 0.800 |
Why?
|
| Dementia | 5 | 2023 | 155 | 0.790 |
Why?
|
| Acetylcholine | 1 | 2022 | 76 | 0.770 |
Why?
|
| Synaptic Transmission | 1 | 2022 | 156 | 0.730 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2025 | 744 | 0.710 |
Why?
|
| Lung Neoplasms | 5 | 2023 | 479 | 0.690 |
Why?
|
| Smoking | 12 | 2025 | 1019 | 0.680 |
Why?
|
| Neurons | 3 | 2020 | 1246 | 0.670 |
Why?
|
| Receptors, Biogenic Amine | 1 | 2020 | 5 | 0.660 |
Why?
|
| Association Learning | 1 | 2020 | 34 | 0.650 |
Why?
|
| Smell | 1 | 2020 | 38 | 0.640 |
Why?
|
| Blood Glucose | 7 | 2025 | 386 | 0.630 |
Why?
|
| Sleep | 2 | 2017 | 179 | 0.570 |
Why?
|
| Retrospective Studies | 20 | 2025 | 2485 | 0.560 |
Why?
|
| Prevalence | 19 | 2024 | 1597 | 0.540 |
Why?
|
| Population Surveillance | 6 | 2021 | 245 | 0.540 |
Why?
|
| Anticoagulants | 5 | 2023 | 121 | 0.530 |
Why?
|
| Esophageal Neoplasms | 4 | 2020 | 137 | 0.530 |
Why?
|
| Peptic Ulcer | 1 | 2016 | 15 | 0.520 |
Why?
|
| Parkinson Disease | 3 | 2024 | 207 | 0.520 |
Why?
|
| Thinness | 4 | 2025 | 32 | 0.500 |
Why?
|
| Anemia | 4 | 2021 | 52 | 0.500 |
Why?
|
| Laryngeal Neoplasms | 3 | 2021 | 13 | 0.490 |
Why?
|
| Diabetic Retinopathy | 4 | 2018 | 77 | 0.490 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2022 | 77 | 0.480 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2021 | 56 | 0.480 |
Why?
|
| Alzheimer Disease | 5 | 2023 | 972 | 0.470 |
Why?
|
| Hemoglobins | 3 | 2021 | 112 | 0.470 |
Why?
|
| Case-Control Studies | 10 | 2025 | 1266 | 0.470 |
Why?
|
| Neoplasms | 3 | 2025 | 1341 | 0.460 |
Why?
|
| Health Surveys | 4 | 2020 | 401 | 0.450 |
Why?
|
| Behavior, Animal | 3 | 2024 | 369 | 0.450 |
Why?
|
| Prediabetic State | 3 | 2022 | 68 | 0.440 |
Why?
|
| Oviposition | 1 | 2014 | 14 | 0.440 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2025 | 21 | 0.440 |
Why?
|
| Lung Diseases, Interstitial | 2 | 2025 | 13 | 0.440 |
Why?
|
| Obesity | 10 | 2023 | 1131 | 0.430 |
Why?
|
| Cardiovascular Diseases | 4 | 2022 | 729 | 0.430 |
Why?
|
| Heart Failure | 4 | 2022 | 298 | 0.430 |
Why?
|
| Behcet Syndrome | 2 | 2025 | 3 | 0.430 |
Why?
|
| Young Adult | 22 | 2025 | 4936 | 0.430 |
Why?
|
| Signal Transduction | 3 | 2024 | 2111 | 0.430 |
Why?
|
| Risk Assessment | 10 | 2025 | 845 | 0.430 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2025 | 19 | 0.420 |
Why?
|
| Aged, 80 and over | 17 | 2021 | 2803 | 0.420 |
Why?
|
| Dermatitis, Atopic | 2 | 2024 | 10 | 0.420 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 88 | 0.410 |
Why?
|
| Follow-Up Studies | 13 | 2024 | 1051 | 0.410 |
Why?
|
| Alcohol Drinking | 9 | 2024 | 585 | 0.400 |
Why?
|
| Cholesterol | 3 | 2025 | 230 | 0.400 |
Why?
|
| Appetitive Behavior | 1 | 2013 | 16 | 0.400 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2024 | 14 | 0.400 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2013 | 24 | 0.400 |
Why?
|
| Blood Pressure | 4 | 2025 | 662 | 0.390 |
Why?
|
| Depression | 4 | 2025 | 837 | 0.390 |
Why?
|
| Stomach Neoplasms | 3 | 2020 | 228 | 0.380 |
Why?
|
| Tachycardia, Ventricular | 2 | 2023 | 14 | 0.380 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 67 | 0.380 |
Why?
|
| Comorbidity | 7 | 2025 | 725 | 0.360 |
Why?
|
| gamma-Glutamyltransferase | 3 | 2023 | 8 | 0.350 |
Why?
|
| Ventricular Premature Complexes | 2 | 2021 | 10 | 0.350 |
Why?
|
| Albuminuria | 3 | 2017 | 78 | 0.350 |
Why?
|
| Disease Susceptibility | 5 | 2021 | 101 | 0.340 |
Why?
|
| Colorectal Neoplasms | 3 | 2023 | 502 | 0.330 |
Why?
|
| Aging | 3 | 2022 | 764 | 0.330 |
Why?
|
| National Health Programs | 5 | 2021 | 19 | 0.320 |
Why?
|
| Brain Infarction | 2 | 2020 | 22 | 0.320 |
Why?
|
| Body Mass Index | 8 | 2023 | 916 | 0.320 |
Why?
|
| Asthma | 2 | 2024 | 410 | 0.310 |
Why?
|
| Sexual Behavior, Animal | 1 | 2010 | 64 | 0.310 |
Why?
|
| Body Height | 2 | 2021 | 53 | 0.310 |
Why?
|
| Cause of Death | 5 | 2022 | 183 | 0.300 |
Why?
|
| Life Style | 2 | 2021 | 326 | 0.290 |
Why?
|
| Hearing Loss | 2 | 2020 | 16 | 0.290 |
Why?
|
| Brain Ischemia | 2 | 2022 | 196 | 0.290 |
Why?
|
| Drosophila | 2 | 2022 | 150 | 0.270 |
Why?
|
| Prognosis | 8 | 2023 | 850 | 0.270 |
Why?
|
| Cholesterol, HDL | 2 | 2025 | 99 | 0.270 |
Why?
|
| Animals | 7 | 2024 | 16695 | 0.270 |
Why?
|
| Longitudinal Studies | 7 | 2025 | 1020 | 0.260 |
Why?
|
| Korea | 4 | 2019 | 37 | 0.240 |
Why?
|
| Ventricular Fibrillation | 2 | 2024 | 9 | 0.240 |
Why?
|
| Antirheumatic Agents | 1 | 2025 | 35 | 0.230 |
Why?
|
| Fibrinolytic Agents | 2 | 2022 | 26 | 0.220 |
Why?
|
| Hyperglycemia | 1 | 2025 | 60 | 0.220 |
Why?
|
| Uterine Neoplasms | 1 | 2025 | 51 | 0.220 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2021 | 30 | 0.220 |
Why?
|
| Smoking Cessation | 2 | 2022 | 583 | 0.220 |
Why?
|
| Leiomyoma | 1 | 2025 | 40 | 0.220 |
Why?
|
| Arteritis | 1 | 2024 | 1 | 0.220 |
Why?
|
| Waist Circumference | 3 | 2021 | 90 | 0.220 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2024 | 2 | 0.220 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2024 | 59 | 0.210 |
Why?
|
| Central Nervous System Depressants | 1 | 2024 | 42 | 0.210 |
Why?
|
| Multivariate Analysis | 7 | 2021 | 638 | 0.210 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2024 | 45 | 0.210 |
Why?
|
| Spinal Cord Injuries | 1 | 2024 | 68 | 0.210 |
Why?
|
| Scleroderma, Systemic | 1 | 2023 | 12 | 0.210 |
Why?
|
| Insulin Resistance | 2 | 2016 | 199 | 0.210 |
Why?
|
| Heart Arrest | 1 | 2024 | 52 | 0.210 |
Why?
|
| Hip Fractures | 1 | 2023 | 29 | 0.200 |
Why?
|
| Locomotion | 1 | 2024 | 104 | 0.200 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2024 | 31 | 0.200 |
Why?
|
| Registries | 3 | 2021 | 431 | 0.200 |
Why?
|
| Wet Macular Degeneration | 1 | 2023 | 3 | 0.200 |
Why?
|
| Fractures, Bone | 1 | 2023 | 61 | 0.200 |
Why?
|
| Administration, Oral | 5 | 2023 | 256 | 0.200 |
Why?
|
| Coronary Artery Disease | 2 | 2025 | 164 | 0.200 |
Why?
|
| Treatment Outcome | 6 | 2024 | 1586 | 0.200 |
Why?
|
| Causality | 1 | 2022 | 45 | 0.200 |
Why?
|
| Social Behavior | 1 | 2024 | 160 | 0.200 |
Why?
|
| Pancreatitis | 1 | 2022 | 21 | 0.190 |
Why?
|
| Pancreatic Neoplasms | 1 | 2025 | 206 | 0.190 |
Why?
|
| Social Environment | 1 | 2024 | 218 | 0.190 |
Why?
|
| Myocardial Ischemia | 1 | 2023 | 82 | 0.190 |
Why?
|
| Postmenopause | 3 | 2022 | 139 | 0.190 |
Why?
|
| Overweight | 3 | 2022 | 248 | 0.190 |
Why?
|
| Weight Gain | 2 | 2020 | 138 | 0.190 |
Why?
|
| Glomerular Filtration Rate | 2 | 2019 | 144 | 0.190 |
Why?
|
| Nasal Obstruction | 1 | 2021 | 2 | 0.180 |
Why?
|
| Lung | 1 | 2025 | 484 | 0.180 |
Why?
|
| Nasal Septum | 1 | 2021 | 4 | 0.180 |
Why?
|
| Lung Diseases | 1 | 2022 | 62 | 0.180 |
Why?
|
| Migraine Disorders | 1 | 2021 | 9 | 0.180 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2021 | 4 | 0.180 |
Why?
|
| Uvula | 1 | 2021 | 1 | 0.180 |
Why?
|
| Palate | 1 | 2021 | 3 | 0.180 |
Why?
|
| Toothbrushing | 1 | 2021 | 11 | 0.180 |
Why?
|
| Proton Pump Inhibitors | 1 | 2021 | 16 | 0.180 |
Why?
|
| Motor Activity | 1 | 2024 | 438 | 0.180 |
Why?
|
| Pharynx | 1 | 2021 | 16 | 0.180 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 223 | 0.170 |
Why?
|
| Diabetes Complications | 1 | 2021 | 99 | 0.170 |
Why?
|
| Appendectomy | 1 | 2020 | 17 | 0.170 |
Why?
|
| Periodontitis | 1 | 2021 | 56 | 0.170 |
Why?
|
| Body Weight | 2 | 2021 | 428 | 0.170 |
Why?
|
| Breast Neoplasms | 2 | 2024 | 1679 | 0.170 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 23 | 0.170 |
Why?
|
| Vitiligo | 1 | 2020 | 3 | 0.170 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 285 | 0.170 |
Why?
|
| Vision, Low | 1 | 2020 | 13 | 0.170 |
Why?
|
| Octopamine | 1 | 2020 | 9 | 0.160 |
Why?
|
| Chromosome Aberrations | 1 | 2020 | 61 | 0.160 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 81 | 0.160 |
Why?
|
| Animals, Genetically Modified | 1 | 2020 | 100 | 0.160 |
Why?
|
| Mouth Neoplasms | 1 | 2020 | 60 | 0.160 |
Why?
|
| Mycobacterium Infections | 1 | 2019 | 16 | 0.160 |
Why?
|
| Hyperuricemia | 1 | 2019 | 13 | 0.160 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2019 | 10 | 0.160 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2020 | 82 | 0.160 |
Why?
|
| Early Detection of Cancer | 2 | 2023 | 428 | 0.150 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 129 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2021 | 253 | 0.150 |
Why?
|
| Cognition | 1 | 2022 | 458 | 0.150 |
Why?
|
| Postoperative Complications | 1 | 2020 | 253 | 0.150 |
Why?
|
| Thiazoles | 1 | 2019 | 76 | 0.150 |
Why?
|
| Infant | 4 | 2024 | 1143 | 0.140 |
Why?
|
| Thyroid Neoplasms | 1 | 2019 | 49 | 0.140 |
Why?
|
| Pyridines | 1 | 2019 | 134 | 0.140 |
Why?
|
| Survivors | 3 | 2024 | 152 | 0.140 |
Why?
|
| Vitamin K | 1 | 2017 | 9 | 0.140 |
Why?
|
| Fibrosis | 3 | 2023 | 166 | 0.140 |
Why?
|
| Dysphonia | 1 | 2017 | 5 | 0.140 |
Why?
|
| Thromboembolism | 1 | 2017 | 20 | 0.140 |
Why?
|
| Proteinuria | 1 | 2017 | 55 | 0.130 |
Why?
|
| Logistic Models | 5 | 2019 | 1001 | 0.130 |
Why?
|
| Hemorrhage | 3 | 2023 | 55 | 0.130 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 41 | 0.130 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2018 | 84 | 0.130 |
Why?
|
| Alcoholism | 1 | 2020 | 292 | 0.130 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 64 | 0.130 |
Why?
|
| Hospitalization | 3 | 2025 | 482 | 0.130 |
Why?
|
| Dyslipidemias | 1 | 2017 | 48 | 0.130 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 175 | 0.120 |
Why?
|
| Olfaction Disorders | 1 | 2016 | 10 | 0.120 |
Why?
|
| Exercise | 4 | 2023 | 674 | 0.120 |
Why?
|
| Risk | 3 | 2021 | 289 | 0.120 |
Why?
|
| Drug Therapy, Combination | 3 | 2022 | 233 | 0.120 |
Why?
|
| Urinary Incontinence | 1 | 2015 | 15 | 0.120 |
Why?
|
| Laryngitis | 1 | 2015 | 2 | 0.120 |
Why?
|
| Blepharoptosis | 1 | 2015 | 4 | 0.120 |
Why?
|
| Tinnitus | 1 | 2015 | 3 | 0.120 |
Why?
|
| Health | 1 | 2015 | 30 | 0.120 |
Why?
|
| Odds Ratio | 4 | 2019 | 587 | 0.110 |
Why?
|
| Oviducts | 1 | 2014 | 13 | 0.110 |
Why?
|
| Particulate Matter | 1 | 2015 | 80 | 0.110 |
Why?
|
| Cataract | 1 | 2015 | 51 | 0.110 |
Why?
|
| Gastritis, Atrophic | 1 | 2014 | 12 | 0.110 |
Why?
|
| Taiwan | 2 | 2024 | 21 | 0.110 |
Why?
|
| Sex Factors | 4 | 2021 | 1008 | 0.110 |
Why?
|
| Infertility, Female | 1 | 2014 | 24 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 573 | 0.110 |
Why?
|
| Anxiety | 1 | 2021 | 847 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 74 | 0.110 |
Why?
|
| Severity of Illness Index | 3 | 2024 | 708 | 0.110 |
Why?
|
| Osteoporosis | 1 | 2014 | 48 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2015 | 90 | 0.100 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 3077 | 0.100 |
Why?
|
| Vitamin D | 1 | 2014 | 196 | 0.100 |
Why?
|
| Warfarin | 2 | 2023 | 66 | 0.090 |
Why?
|
| Age Factors | 3 | 2021 | 1139 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 928 | 0.080 |
Why?
|
| Quality of Life | 1 | 2015 | 599 | 0.080 |
Why?
|
| Sex Attractants | 1 | 2010 | 4 | 0.080 |
Why?
|
| Genes, Insect | 1 | 2010 | 27 | 0.080 |
Why?
|
| Vibration | 1 | 2010 | 23 | 0.080 |
Why?
|
| Touch | 1 | 2010 | 19 | 0.080 |
Why?
|
| Child | 3 | 2024 | 3381 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2024 | 960 | 0.080 |
Why?
|
| Survival Rate | 2 | 2021 | 353 | 0.080 |
Why?
|
| Vocalization, Animal | 1 | 2010 | 54 | 0.080 |
Why?
|
| Adolescent | 4 | 2024 | 5950 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 1068 | 0.080 |
Why?
|
| Creatinine | 2 | 2019 | 102 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2024 | 1516 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2025 | 1574 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 382 | 0.070 |
Why?
|
| Spirometry | 1 | 2025 | 40 | 0.060 |
Why?
|
| Respiratory Function Tests | 1 | 2025 | 61 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2025 | 73 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2010 | 722 | 0.060 |
Why?
|
| Forced Expiratory Volume | 1 | 2025 | 75 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 2 | 2015 | 157 | 0.060 |
Why?
|
| Mutation | 1 | 2010 | 1169 | 0.060 |
Why?
|
| Triglycerides | 1 | 2025 | 146 | 0.060 |
Why?
|
| Anthracyclines | 1 | 2024 | 9 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2024 | 62 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 1221 | 0.050 |
Why?
|
| Rifampin | 1 | 2023 | 8 | 0.050 |
Why?
|
| Antitubercular Agents | 1 | 2023 | 33 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2023 | 92 | 0.050 |
Why?
|
| Acute Disease | 1 | 2022 | 156 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 58 | 0.050 |
Why?
|
| Heart Function Tests | 1 | 2021 | 12 | 0.050 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2021 | 1 | 0.040 |
Why?
|
| Oral Surgical Procedures | 1 | 2021 | 4 | 0.040 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2021 | 2 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2021 | 17 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2021 | 19 | 0.040 |
Why?
|
| Estrogens | 1 | 2022 | 202 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2021 | 116 | 0.040 |
Why?
|
| Time Factors | 1 | 2025 | 1848 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2021 | 71 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2021 | 184 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 30 | 0.040 |
Why?
|
| Gastroscopy | 1 | 2019 | 9 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2020 | 133 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2020 | 117 | 0.040 |
Why?
|
| Chest Pain | 1 | 2020 | 49 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 2018 | 19 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 153 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2019 | 29 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2019 | 38 | 0.040 |
Why?
|
| Patient Participation | 1 | 2019 | 87 | 0.040 |
Why?
|
| Liver | 1 | 2021 | 503 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2018 | 30 | 0.040 |
Why?
|
| Weight Loss | 1 | 2019 | 138 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2019 | 411 | 0.030 |
Why?
|
| Mortality | 1 | 2018 | 174 | 0.030 |
Why?
|
| Fasting | 1 | 2017 | 56 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 727 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 438 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 362 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 487 | 0.030 |
Why?
|
| Reference Values | 1 | 2016 | 207 | 0.030 |
Why?
|
| Premenopause | 1 | 2016 | 109 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 1737 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2015 | 162 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 249 | 0.030 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 29 | 0.030 |
Why?
|
| Seasons | 1 | 2015 | 133 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1554 | 0.030 |
Why?
|
| Particle Size | 1 | 2015 | 267 | 0.030 |
Why?
|
| Influenza Vaccines | 1 | 2015 | 55 | 0.030 |
Why?
|
| Insulin | 1 | 2016 | 255 | 0.030 |
Why?
|
| Eating | 1 | 2015 | 164 | 0.030 |
Why?
|
| Data Collection | 1 | 2014 | 210 | 0.030 |
Why?
|
| Income | 1 | 2015 | 160 | 0.030 |
Why?
|
| Lipids | 1 | 2015 | 256 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2015 | 541 | 0.020 |
Why?
|